Application
CU002 Antibody (C-term) western blot analysis in MDA-MB435 cell line lysates (35ug/lane).This demonstrates the CU002 antibody detected the CU002 protein (arrow).Application
CU002 Antibody (C-term) flow cytometric analysis of MDA-MB435 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CU002 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | C21orf2; Uncharacterized protein C21orf2; C21orf-HUMF09G8.5; YF5/A2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | C21orf2 Uncharacterized protein C21orf2 C21orf-HUMF09G8.5 YF5/A2 |
|---|---|
| Molecular Weight(MW) | 28340 Da |
| Function | May play roles in cilia formation and/or maintenance (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization |
| Tissue Specificity | This CU002 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 172-202 amino acids from the C-terminal region of human CU002. |
| Entrez Gene | 755 |
|---|---|
| Nucleotide Accession | NP_004919.1 |
Application
CU002 Antibody (C-term) western blot analysis in MDA-MB435 cell line lysates (35ug/lane).This demonstrates the CU002 antibody detected the CU002 protein (arrow).
Application
CU002 Antibody (C-term) flow cytometric analysis of MDA-MB435 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
